Cantrell Drug Company Recalls

All product recalls associated with Cantrell Drug Company.

Get alerts for this brand

Recall Summary

Total Recalls

52

Past Year

0

Class I (Serious)

7

Most Recent

Jul 2017

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 1–20 of 52 recalls

Succinylcholine Chloride Injection (Cantrell Drug) – sterility risk (2017)

Lack of Sterility Assurance.

Class IIModerate

FDAJul 14, 2017Nationwide• Cantrell Drug Company

Norepinephrine Bitartrate IV Solution (Cantrell Drug) – sterility risk (2017)

Lack of Sterility Assurance.

Class IIModerate

FDAJul 14, 2017Nationwide• Cantrell Drug Company

Ephedrine Sulfate Injection (Cantrell Drug) – sterility risk (2017)

Lack of Sterility Assurance.

Class IIModerate

FDA

Jul 14, 2017

Nationwide

• Cantrell Drug Company

Sodium Bicarbonate Injection (Cantrell Drug) – sterility risk (2017)

Lack of Sterility Assurance.

Class IIModerate

FDAJul 14, 2017Nationwide• Cantrell Drug Company

Norepinephrine Bitartrate IV Solution (Cantrell Drug) – sterility risk (2017)

Lack of Sterility Assurance.

Class IIModerate

FDAJul 14, 2017Nationwide• Cantrell Drug Company

Glycopyrrolate Injection (Cantrell) - Sterility Risk (2017)

Lack of Sterility Assurance.

Class IIModerate

FDAJul 14, 2017Nationwide• Cantrell Drug Company

Diltiazem HCl IV Solution (Cantrell Drug) – sterility risk (2017)

Lack of Sterility Assurance.

Class IIModerate

FDAJul 14, 2017Nationwide• Cantrell Drug Company

Norepinephrine Bitartrate IV Solution (Cantrell Drug) – sterility risk (2017)

Lack of Sterility Assurance.

Class IIModerate

FDAJul 14, 2017Nationwide• Cantrell Drug Company

Neostigmine Injection (Cantrell) - Sterility Risk (2017)

Lack of Sterility Assurance.

Class IIModerate

FDAJul 14, 2017Nationwide• Cantrell Drug Company

Ephedrine Sulfate Injection (Cantrell Drug) – sterility risk (2017)

Lack of Sterility Assurance.

Class IIModerate

FDAJul 14, 2017Nationwide• Cantrell Drug Company

Succinylcholine Chloride Injection (Cantrell Drug) – sterility risk (2017)

Lack of Sterility Assurance.

Class IIModerate

FDAJul 14, 2017Nationwide• Cantrell Drug Company

Adenosine Sodium Chloride Injection (Cantrell Drug) – sterility risk (2017)

Lack of Sterility Assurance.

Class IIModerate

FDAJul 14, 2017Nationwide• Cantrell Drug Company

Glycopyrrolate Injection (Cantrell Drug) – sterility risk (2017)

Lack of Sterility Assurance.

Class IIModerate

FDAJul 14, 2017Nationwide• Cantrell Drug Company

Ephedrine Sulfate Injection (Cantrell Drug) – sterility risk (2017)

Lack of Sterility Assurance.

Class IIModerate

FDAJul 14, 2017Nationwide• Cantrell Drug Company

Rocuronium Bromide Injection (Cantrell Drug) – sterility risk (2017)

Lack of Sterility Assurance.

Class IIModerate

FDAJul 14, 2017Nationwide• Cantrell Drug Company

Glycopyrrolate Injection (Cantrell Drug) – sterility risk (2017)

Lack of Sterility Assurance.

Class IIModerate

FDAJul 14, 2017Nationwide• Cantrell Drug Company

Phenylephrine HCL Injection (Cantrell) - Sterility Risk (2017)

Lack of Sterility Assurance.

Class IIModerate

FDAJul 14, 2017Nationwide• Cantrell Drug Company

Ephedrine Sulfate Injection (Cantrell) - Sterility Risk (2017)

Lack of Sterility Assurance.

Class IIModerate

FDAJul 14, 2017Nationwide• Cantrell Drug Company

Glycopyrrolate Injection (Cantrell Drug) – sterility concerns (2016)

Lack of Assurance of Sterility - the firm is recalling select sterile drug products.

Class IIModerate

FDANov 18, 2016Nationwide• Cantrell Drug Company

Rocuronium Bromide Injection (Cantrell) – sterility concern (2016)

Lack of Assurance of Sterility - the firm is recalling select sterile drug products.

Class IIModerate

FDANov 18, 2016Nationwide• Cantrell Drug Company

Stay Informed

Cantrell Drug Company Recalls

Recall Summary

Succinylcholine Chloride Injection (Cantrell Drug) – sterility risk (2017)

Norepinephrine Bitartrate IV Solution (Cantrell Drug) – sterility risk (2017)

Ephedrine Sulfate Injection (Cantrell Drug) – sterility risk (2017)

Sodium Bicarbonate Injection (Cantrell Drug) – sterility risk (2017)

Norepinephrine Bitartrate IV Solution (Cantrell Drug) – sterility risk (2017)

Glycopyrrolate Injection (Cantrell) - Sterility Risk (2017)

Diltiazem HCl IV Solution (Cantrell Drug) – sterility risk (2017)

Norepinephrine Bitartrate IV Solution (Cantrell Drug) – sterility risk (2017)

Neostigmine Injection (Cantrell) - Sterility Risk (2017)

Ephedrine Sulfate Injection (Cantrell Drug) – sterility risk (2017)

Succinylcholine Chloride Injection (Cantrell Drug) – sterility risk (2017)

Adenosine Sodium Chloride Injection (Cantrell Drug) – sterility risk (2017)

Glycopyrrolate Injection (Cantrell Drug) – sterility risk (2017)

Ephedrine Sulfate Injection (Cantrell Drug) – sterility risk (2017)

Rocuronium Bromide Injection (Cantrell Drug) – sterility risk (2017)

Glycopyrrolate Injection (Cantrell Drug) – sterility risk (2017)

Phenylephrine HCL Injection (Cantrell) - Sterility Risk (2017)

Ephedrine Sulfate Injection (Cantrell) - Sterility Risk (2017)

Glycopyrrolate Injection (Cantrell Drug) – sterility concerns (2016)

Rocuronium Bromide Injection (Cantrell) – sterility concern (2016)